The majority of these follow-on patents were filed between 2021 and 2022, coinciding with the launches of Mounjaro and Zepbound (Figure 10)
By the time most patients walk into our Conshohocken office, theyre experiencing the downstream effects: stubborn belly fat, poor sleep quality, slower recovery, thinning skin, and a general sense that their body simply doesnt bounce back like it used to
In early studies, people on higher doses of retatrutide lost more than 20 percent of their body weight on average, which is higher than the results seen with many current drugs
SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) increase urinary glucose excretion, creating a glucose-rich environment in the genitourinary tract that promotes fungal overgrowth